You said you’d have to be foolish. I said that you probably shouldn’t think of yourself as foolish. It’s not ad hominem. I am not going to address your persona

You said you’d have to be foolish. I said that you probably shouldn’t think of yourself as foolish. It’s not ad hominem. I am not going to address your personal comments. Having said that..you said [..] Indeed I do. I have deep knowledge of the process in two markets. I also have a very good knowledge of the homeopathic industry. There have been thousands of homeopathy clinical trials. None has ever proven any effectiveness beyond placebo. So, I asked not for pharmaceutical industry level studies, but for academic level - that’s a much lower bar.[..] There is not enough information. Can you elaborate about your ‘deep knowledge’ and what is your ‘good knowledge of the homeopathic industry’? What ‘two markets’? Links? Meanwhile: https://publichealth.jhu.edu/2018/cost-of-clinical-trials-for-new-drug-FDA-approval-are-fraction-of-total-tab https://publichealth.jhu.edu/2018/cost-of-clinical-trials-fo... [..] Clinical trials that support FDA approvals of new drugs have a median cost of $19 million, according to a new study by a team including researchers from Johns Hopkins Bloomberg School of Public Health.[..] https://www.sofpromed.com/how-much-does-a-clinical-trial-cost https://www.sofpromed.com/how-much-does-a-clinical-trial-cos... [..] How much does a clinical trial cost? The average cost of phase 1, 2, and 3 clinical trials across therapeutic areas is around $4, 13, and 20 million respectively. Pivotal (phase 3) studies for new drugs approved by the Food and Drug Administration (FDA) of the United States cost a median of $41,117 per patient. The above-mentioned cost estimates across therapeutic areas were reported by Aylin Sertkaya et al., in a report submitted to the U.S. Department of Health and Human Services, containing Table 1 below.[..]